Friday, 6 October 2017

Flexion's knee pain drug gets FDA nod

(Reuters) - Flexion Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its drug, Zilretta, to treat moderate-to-severe osteoarthritis-related knee pain.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)